PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1984 November; 77(11): 936–942.
PMCID: PMC1440185

Ocular manifestations of Graves' disease: a review.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.3M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Amino N, Yuasa T, Yabu Y, Miyai K, Kumahara Y. Exophthalmos in autoimmune thyroid disease. J Clin Endocrinol Metab. 1980 Dec;51(6):1232–1234. [PubMed]
  • Apers RC, Oosterhuis JA, Bierlaagh JJ. Indications and results of prednisone treatment in thyroid ophthalmopathy. Ophthalmologica. 1976;173(3-4):163–167. [PubMed]
  • Bartalena L, Marcocci C, Chiovato L, Laddaga M, Lepri G, Andreani D, Cavallacci G, Baschieri L, Pinchera A. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. J Clin Endocrinol Metab. 1983 Jun;56(6):1139–1144. [PubMed]
  • Bigos ST, Nisula BC, Daniels GH, Eastman RC, Johnston HH, Kohler PO. Cyclophosphamide in the management of advanced Graves' ophthalmopathy. A preliminary report. Ann Intern Med. 1979 Jun;90(6):921–923. [PubMed]
  • Blau HM, Kaplan I, Tao TW, Kriss JP. Thyroglobulin-independent, cell-mediated cytotoxicity of human eye muscle cells in tissue culture by lymphocytes of a patient with Graves' ophthalmopathy. Life Sci. 1983 Jan 3;32(1-2):45–53. [PubMed]
  • Brabant G, Peter H, Becker H, Schwarzrock R, Wonigeit K, Hesch RD. Cyclosporin in infiltrative eye disease. Lancet. 1984 Mar 3;1(8375):515–516. [PubMed]
  • Brohee D, Delespesse G, Debisschop MJ, Bonnyns M. Circulating immune complexes in various thyroid diseases. Clin Exp Immunol. 1979 Jun;36(3):379–383. [PubMed]
  • Burrow GN, Mitchell MS, Howard RO, Morrow LB. Immunosuppressive therapy for the eye changes of Graves' disease. J Clin Endocrinol Metab. 1970 Sep;31(3):307–311. [PubMed]
  • Burrows AW, Barnett D. Diagnostic problems in unilateral proptosis. Lancet. 1981 Feb 28;1(8218):495–495. [PubMed]
  • Covington EE, Lobes L, Sudarsanam A. Radiation therapy for exophthalmos: report of seven cases. Radiology. 1977 Mar;122(3):797–799. [PubMed]
  • DeSanto LW. The total rehabilitation of Graves' ophthalmopathy. Laryngoscope. 1980 Oct;90(10 Pt 1):1652–1678. [PubMed]
  • DOBYNS BM. Present concepts of the pathologic physiology of exophthalmos. J Clin Endocrinol Metab. 1950 Oct;10(10):1202–1230. [PubMed]
  • Enzmann D, Donaldson SS, Marshall WH, Kriss JP. Computed tomography in orbital pseudothumor (idiopathic orbital inflammation). Radiology. 1976 Sep;120(3):597–601. [PubMed]
  • Feek CM, Donaldson AA, Toft AD. Endocrine exophthalmos or orbital pseudotumour. Lancet. 1981 Jan 24;1(8213):217–218. [PubMed]
  • FURTH ED, BECKER DV, RAY BS, KANE JW. Appearance of unilateral infiltrative exophthalmos of Graves' disease after the successful treatment of the same process in the contralateral eye by apparently total surgical hypophysectomy. J Clin Endocrinol Metab. 1962 May;22:518–524. [PubMed]
  • Gamblin GT, Harper DG, Galentine P, Buck DR, Chernow B, Eil C. Prevalence of increased intraocular pressure in Graves' disease--evidence of frequent subclinical ophthalmopathy. N Engl J Med. 1983 Feb 24;308(8):420–424. [PubMed]
  • Gorman CA, DeSanto LW, MacCarty CS, Riley FC. Optic neuropathy of graves's disease. Treatment by transantral or transfrontal orbital decompression. N Engl J Med. 1974 Jan 10;290(2):70–75. [PubMed]
  • Gwinup G, Elias AN, Ascher MS. Effect on exophthalmos of various methods of treatment of Graves' disease. JAMA. 1982 Apr 16;247(15):2135–2138. [PubMed]
  • Henderson J, Wall JR. Failure of haemagglutination and immunofluorescence methods to detect serum orbital antibodies in patients with Graves' ophthalmopathy. Clin Endocrinol (Oxf) 1981 Feb;14(2):153–158. [PubMed]
  • Kelly W, Longson D, Smithard D, Fawcitt R, Wensley R, Noble J, Keeley J. An evaluation of plasma exchange for Graves' ophthalmopathy. Clin Endocrinol (Oxf) 1983 May;18(5):485–493. [PubMed]
  • Kendall-Taylor P, Atkinson S, Holcombe M. A specific IgG in Graves' ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity. Br Med J (Clin Res Ed) 1984 Apr 21;288(6425):1183–1186. [PMC free article] [PubMed]
  • Kodama K, Sikorska H, Bandy-Dafoe P, Bayly R, Wall JR. Demonstration of a circulating autoantibody against a soluble eye-muscle antigen in Graves' ophthalmopathy. Lancet. 1982 Dec 18;2(8312):1353–1356. [PubMed]
  • Kohn LD, Winand RJ. Structure of an exophthalmos-producing factor derived from thyrotropin by partial pepsin digestion. J Biol Chem. 1975 Aug 25;250(16):6503–6508. [PubMed]
  • Konishi J, Herman MM, Kriss JP. Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex to extraocular muscle membrane. Endocrinology. 1974 Aug;95(2):434–446. [PubMed]
  • Kriss JP. Radioisotopic thyroidolymphography in patients with Graves' disease. J Clin Endocrinol Metab. 1970 Sep;31(3):315–323. [PubMed]
  • Kriss JP, Mehdi SQ. Cell-mediated lysis of lipid vesicles containing eye muscle protein: implications regarding pathogenesis of Graves ophthalmopathy. Proc Natl Acad Sci U S A. 1979 Apr;76(4):2003–2007. [PubMed]
  • Linberg JV, Anderson RL. Transorbital decompression. Indications and results. Arch Ophthalmol. 1981 Jan;99(1):113–119. [PubMed]
  • McKenzie JM. Humoral factors in the pathogenesis of Graves' disease. Physiol Rev. 1968 Jan;48(1):252–310. [PubMed]
  • Mullin BR, Levinson RE, Friedman A, Henson DE, Winand RJ, Kohn LD. Delayed hypersensitivity in Graves' disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle. Endocrinology. 1977 Feb;100(2):351–366. [PubMed]
  • Munro RE, Lamki L, Row VV, Volpé R. Cell-mediated immunity in the exophthalmos of Graves' disease as demonstrated by the migration inhibition factor (MIF) test. J Clin Endocrinol Metab. 1973 Aug;37(2):286–292. [PubMed]
  • Ormston BJ, Alexander L, Evered DC, Clark F, Bird T, Appleton D, Hall R. Thyrotrophin response to thyrotrophin-releasing hormone in ophthalmic Graves' disease: correlation with other aspects of thyroid function, thyroid suppressibility and activity of eye signs. Clin Endocrinol (Oxf) 1973 Oct;2(4):369–376. [PubMed]
  • Teng CS, Crombie AL, Hall R, Ross WM. An evaluation of supervoltage orbital irradiation for Graves' ophthalmopathy. Clin Endocrinol (Oxf) 1980 Dec;13(6):545–551. [PubMed]
  • Teng CS, Smith BR, Clayton B, Evered DC, Clark F, Hall R. Thyroid-stimulating immunoglobulins in ophthalmic Graves' disease. Clin Endocrinol (Oxf) 1977 Mar;6(3):207–211. [PubMed]
  • Teng CS, Yeo PP. Ophthalmic Graves's disease: natural history and detailed thyroid function studies. Br Med J. 1977 Jan 29;1(6056):273–275. [PMC free article] [PubMed]
  • Thomason AM, Nusynowitz ML. Thionamides for hyperthyroidism: on a clear day you can treat forever. JAMA. 1979 Nov 30;242(22):2437–2437. [PubMed]
  • Trokel SL, Jakobiec FA. Correlation of CT scanning and pathologic features of ophthalmic Graves' disease. Ophthalmology. 1981 Jun;88(6):553–564. [PubMed]
  • Wall JR, Strakosch CR, Fang SL, Ingbar SH, Braverman LE. Thyroid binding antibodies and other immunological abnormalities in patients with Graves' ophthalmopathy: effect of treatment with cyclophosphamide. Clin Endocrinol (Oxf) 1979 Jan;10(1):79–91. [PubMed]
  • Wall JR, Trewin A, Fang SL, Ingbar SH, Braverman LE. Studies of immunoreactivity to human lacrimal gland fractions in patients with ophthalmic Graves' disease. J Endocrinol Invest. 1978 Jul;1(3):253–258. [PubMed]
  • Weetman AP, McGregor AM, Ludgate M, Beck L, Mills PV, Lazarus JH, Hall R. Cyclosporin improves Graves' ophthalmopathy. Lancet. 1983 Aug 27;2(8348):486–489. [PubMed]
  • Weetman AP, McGregor AM. Autoimmune thyroid disease: developments in our understanding. Endocr Rev. 1984 Spring;5(2):309–355. [PubMed]
  • Weetman AP, Pinching AJ, Pussel BA, Evans DJ, Sweny P, Rees AJ. Membranous glomerulonephritis and autoimmune thyroid disease. Clin Nephrol. 1981 Jan;15(1):50–51. [PubMed]
  • Werner SC, Coleman DJ, Franzen LA. Ultrasonographic evidence of a consistent orbital involvement in Graves's disease. N Engl J Med. 1974 Jun 27;290(26):1447–1450. [PubMed]
  • Winand RJ, Kohn LD. The binding of ( 3 H)thyrotropin and an 3 H-labeled exophthalmogenic factor by plasma membranes of retro-orbital tissue. Proc Natl Acad Sci U S A. 1972 Jul;69(7):1711–1715. [PubMed]
  • Zakarija M, McKenzie JM, Banovac K. Clinical significance of assay of thyroid-stimulating antibody in Graves' disease. Ann Intern Med. 1980 Jul;93(1):28–32. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press